|
1
|
Sempoux C, Jibara G, Ward SC, Fan C, Qin
L, Roayaie S, Fiel MI, Schwartz M and Thung SN: Intrahepatic
cholangiocarcinoma: New insights in pathology. Semin Liver Dis.
31:49–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shaib YH, Davila JA, McGlynn K and
El-Serag HB: Rising incidence of intrahepatic cholangiocarcinoma in
the United States: A true increase? J Hepatol. 40:472–477. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou
Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, et
al: Intrahepatic cholangiocarcinoma: Rising frequency, improved
survival, and determinants of outcome after resection. Ann Surg.
248:84–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tamandl D, Herberger B, Gruenberger B,
Puhalla H, Klinger M and Gruenberger T: Influence of hepatic
resection margin on recurrence and survival in intrahepatic
cholangiocarcinoma. Ann Surg Oncol. 15:2787–2794. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou XD, Tang ZY, Fan J, Zhou J, Wu ZQ,
Qin LX, Ma ZC, Sun HC, Qiu SJ, Yu Y, et al: Intrahepatic
cholangiocarcinoma: Report of 272 patients compared with 5,829
patients with hepatocellular carcinoma. J Cancer Res Clin Oncol.
135:1073–1080. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lang H, Sotiropoulos GC, Frühauf NR,
Dömland M, Paul A, Kind EM, Malagó M and Broelsch CE: Extended
hepatectomy for intrahepatic cholangiocellular carcinoma (ICC):
When is it worthwhile? Single center experience with 27 resections
in 50 patients over a 5-year period. Ann Surg. 241:134–143.
2005.
|
|
7
|
Tan JC, Coburn NG, Baxter NN, Kiss A and
Law CH: Surgical management of intrahepatic cholangiocarcinoma - a
population-based study. Ann Surg Oncol. 15:600–608. 2008.
View Article : Google Scholar
|
|
8
|
Jonas S, Thelen A, Benckert C, Biskup W,
Neumann U, Rudolph B, Lopez-Hänninen E and Neuhaus P: Extended
liver resection for intrahepatic cholangiocarcinoma: A comparison
of the prognostic accuracy of the fifth and sixth editions of the
TNM classification. Ann Surg. 249:303–309. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohtsuka M, Ito H, Kimura F, Shimizu H,
Togawa A, Yoshidome H and Miyazaki M: Results of surgical treatment
for intrahepatic cholangiocarcinoma and clinicopathological factors
influencing survival. Br J Surg. 89:1525–1531. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakagohri T, Asano T, Kinoshita H,
Kenmochi T, Urashima T, Miura F and Ochiai T: Aggressive surgical
resection for hilar-invasive and peripheral intrahepatic
cholangiocarcinoma. World J Surg. 27:289–293. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimada M, Yamashita Y, Aishima S, Shirabe
K, Takenaka K and Sugimachi K: Value of lymph node dissection
during resection of intrahepatic cholangiocarcinoma. Br J Surg.
88:1463–1466. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Konstadoulakis MM, Roayaie S, Gomatos IP,
Labow D, Fiel MI, Miller CM and Schwartz ME: Fifteen-year,
single-center experience with the surgical management of
intrahepatic cholangiocarcinoma: Operative results and long-term
outcome. Surgery. 143:366–374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lang H, Sotiropoulos GC, Sgourakis G,
Schmitz KJ, Paul A, Hilgard P, Zöpf T, Trarbach T, Malagó M, Baba
HA, et al: Operations for intrahepatic cholangiocarcinoma:
Single-institution experience of 158 patients. J Am Coll Surg.
208:218–228. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Urahashi T, Yamamoto M, Ohtsubo T,
Katsuragawa H, Katagiri S and Takasaki K:
Hepatopancreatoduodenectomy could be allowed for patients with
advanced intrahepatic cholangiocarcinoma. Hepatogastroenterology.
54:346–349. 2007.PubMed/NCBI
|
|
15
|
Wu ZF, Zhang HB, Yang N, Zhao WC, Fu Y and
Yang GS: Postoperative adjuvant transcatheter arterial
chemoembolisation improves survival of intrahepatic
cholangiocarcinoma patients with poor prognostic factors: Results
of a large monocentric series. Eur J Surg Oncol. 38:602–610. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho SY, Park SJ, Kim SH, Han SS, Kim YK,
Lee KW, Lee SA, Hong EK, Lee WJ and Woo SM: Survival analysis of
intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol.
17:1823–1830. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie
F, Sui CJ and Yang JM: Clinicopathological and prognostic analysis
of 429 patients with intrahepatic cholangiocarcinoma. World J
Gastroenterol. 15:5976–5982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uenishi T, Yamazaki O, Yamamoto T,
Hirohashi K, Tanaka H, Tanaka S, Hai S and Kubo S: Serosal invasion
in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J
Hepatobiliary Pancreat Surg. 12:479–483. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; New York, NY: 2010
|
|
20
|
Farges O, Fuks D, Boleslawski E, Le Treut
YP, Castaing D, Laurent A, Ducerf C, Rivoire M, Bachellier P,
Chiche L, et al: Influence of surgical margins on outcome in
patients with intrahepatic cholangiocarcinoma: A multicenter study
by the AFC-IHCC-2009 study group. Ann Surg. 254:824–829; discussion
830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shimada K, Sano T, Sakamoto Y, Esaki M,
Kosuge T and Ojima H: Clinical impact of the surgical margin status
in hepatectomy for solitary mass-forming type intrahepatic
cholangiocarcinoma without lymph node metastases. J Surg Oncol.
96:160–165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liver Cancer Study Group of Japan: The
general rules for the clinical and pathological study of primary
liver cancer. Jpn J Surg. 19:98–129. 1989. View Article : Google Scholar
|
|
24
|
Clavien PA, Barkun J, de Oliveira ML,
Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J,
Slankamenac K, Bassi C, et al: The Clavien-Dindo classification of
surgical complications: Five-year experience. Ann Surg.
250:187–196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo X, Yuan L, Wang Y, Ge R, Sun Y and Wei
G: Survival outcomes and prognostic factors of surgical therapy for
all potentially resectable intrahepatic cholangiocarcinoma: A large
single-center cohort study. J Gastrointest Surg. 18:562–572. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan
Z, Wan X, Liu G, Wu D, Shi L, et al: Prognostic nomogram for
intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin
Oncol. 31:1188–1195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tamandl D, Kaczirek K, Gruenberger B,
Koelblinger C, Maresch J, Jakesz R and Gruenberger T: Lymph node
ratio after curative surgery for intrahepatic cholangiocarcinoma.
Br J Surg. 96:919–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paik KY, Jung JC, Heo JS, Choi SH, Choi DW
and Kim YI: What prognostic factors are important for resected
intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol.
23:766–770. 2008. View Article : Google Scholar
|
|
29
|
Uchiyama K, Yamamoto M, Yamaue H, Ariizumi
S, Aoki T, Kokudo N, Ebata T, Nagino M, Ohtsuka M, Miyazaki M, et
al: Impact of nodal involvement on surgical outcomes of
intrahepatic cholangiocarcinoma: A multicenter analysis by the
Study Group for Hepatic Surgery of the Japanese Society of
Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci.
18:443–452. 2011. View Article : Google Scholar
|
|
30
|
Shirabe K, Mano Y, Taketomi A, Soejima Y,
Uchiyama H, Aishima S, Kayashima H, Ninomiya M and Maehara Y:
Clinicopathological prognostic factors after hepatectomy for
patients with mass-forming type intrahepatic cholangiocarcinoma:
Relevance of the lymphatic invasion index. Ann Surg Oncol.
17:1816–1822. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Jong MC, Nathan H, Sotiropoulos GC,
Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM,
Aldrighetti L, et al: Intrahepatic cholangiocarcinoma: An
international multi-institutional analysis of prognostic factors
and lymph node assessment. J Clin Oncol. 29:3140–3145. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Park J, Kim MH, Kim KP, Park H, Moon SH,
Song TJ, Eum J, Lee SS, Seo DW and Lee SK: Natural History and
Prognostic Factors of Advanced Cholangiocarcinoma without Surgery,
Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.
Gut Liver. 3:298–305. 2009. View Article : Google Scholar
|
|
33
|
Dhanasekaran R, Hemming AW, Zendejas I,
George T, Nelson DR, Soldevila-Pico C, Firpi RJ, Morelli G, Clark V
and Cabrera R: Treatment outcomes and prognostic factors of
intrahepatic cholangiocarcinoma. Oncol Rep. 29:1259–1267.
2013.PubMed/NCBI
|
|
34
|
Puhalla H, Schuell B, Pokorny H, Kornek
GV, Scheithauer W and Gruenberger T: Treatment and outcome of
intrahepatic cholangiocellular carcinoma. Am J Surg. 189:173–177.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou HB, Wang H, Li YQ, Li SX, Wang H,
Zhou DX, Tu QQ, Wang Q, Zou SS, Wu MC, et al: Hepatitis B virus
infection: A favorable prognostic factor for intrahepatic
cholangiocarcinoma after resection. World J Gastroenterol.
17:1292–1303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang BG, Sun LL, Yu WL, Tang ZH, Zong M
and Zhang YJ: Retrospective analysis of histopathologic prognostic
factors after hepatectomy for intrahepatic cholangiocarcinoma.
Cancer J. 15:257–261. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karpeh MS Jr: Palliative treatment and the
role of surgical resection in gastric cancer. Dig Surg. 30:174–180.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Suh KS, Chang SH, Lee HJ, Roh HR, Kim SH
and Lee KU: Clinical outcomes and apomucin expression of
intrahepatic cholangiocarcinoma according to gross morphology. J Am
Coll Surg. 195:782–789. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
DeOliveira ML, Cunningham SC, Cameron JL,
Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ and Schulick
RD: Cholangiocarcinoma: Thirty-one-year experience with 564
patients at a single institution. Ann Surg. 245:755–762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Inoue K, Makuuchi M, Takayama T, Torzilli
G, Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Konishi M,
Kinoshita T, et al: Long-term survival and prognostic factors in
the surgical treatment of mass-forming type cholangiocarcinoma.
Surgery. 127:498–505. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Patel T: Increasing incidence and
mortality of primary intrahepatic cholangiocarcinoma in the United
States. Hepatology. 33:1353–1357. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Grobmyer SR, Wang L, Gonen M, Fong Y,
Klimstra D, D'Angelica M, DeMatteo RP, Schwartz L, Blumgart LH and
Jarnagin WR: Perihepatic lymph node assessment in patients
undergoing partial hepatectomy for malignancy. Ann Surg.
244:260–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kitagawa Y, Nagino M, Kamiya J, Uesaka K,
Sano T, Yamamoto H, Hayakawa N and Nimura Y: Lymph node metastasis
from hilar cholangiocarcinoma: Audit of 110 patients who underwent
regional and paraaortic node dissection. Ann Surg. 233:385–392.
2001. View Article : Google Scholar : PubMed/NCBI
|
